Clara David

Namur, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count.

Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 10, 2025

Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosis.

Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosis.

Journal: Research and practice in thrombosis and haemostasis

Published: October 13, 2024

Equine adult, fetal and ESC-tenocytes have differential migratory, proliferative and gene expression responses to factors upregulated in the injured tendon.

Equine adult, fetal and ESC-tenocytes have differential migratory, proliferative and gene expression responses to factors upregulated in the injured tendon.

Journal: Cells & development

Published: October 11, 2024

Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study.

Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study.

Journal: Heliyon

Published: October 01, 2024

Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.

Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.

Journal: Clinical chemistry and laboratory medicine

Published: August 08, 2024

Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?

Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?

Journal: Heliyon

Published: February 02, 2024

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 16, 2024

Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.

Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.

Journal: Journal of medical virology

Published: September 26, 2023

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.

Journal: Journal of medical virology

Published: August 03, 2022

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

Journal: Biomolecules

Published: May 23, 2022

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity.

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity.

Journal: Viruses

Published: May 20, 2022

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.

Journal: The Journal of infection

Published: January 11, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026